Product Code: PM2573
The global Infectious Disease In Vitro Diagnostics market size is expected to reach USD 62.83 billion by 2030, according to a new study by Polaris Market Research. The report "Infectious Disease In Vitro Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents, Software); By Application (MRSA, VRE, Streptococcus); By Technology; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides an analysis of future market growth.
The growing infectious diseases across the globe, people's awareness, and technological adoption are the drivers for the IVD test. Furthermore, COVID-19 tests, the increasing geriatric population, and user-friendly devices with low cost and high efficiency are the major factors driving demand.
In addition, the growing geriatric population & spread of acute as well as chronic diseases across developing economies such as India, Japan, and China is likely to positively impact the demand for IVD devices over the coming years. However, the increase in disease will increase the number of tests over the forecasting period.
The COVID-19 pandemic has positively affected the expansion of the market, as the detection of the COVID test was mandatory, whether positive or negative. The emergence of the COVID-19 increased awareness among people, increasing regular health checkup tests. It is estimated that the market will keep rising over the forecasting period.
Infectious Disease In Vitro Diagnostics Market Report Highlights
Molecular diagnostics technology is increasing as it uses advanced technology with low cost, and better results.
The reagent segment accounted for the highest revenue share in 2021 and is expected to continue its dominance owing to many tests for detecting diseases and people's awareness.
Infectious diseases contributed a higher share of revenue owing to COVID-19 testing globally. The conditions are spreading widely, thus resulting in the number of tests for infectious diseases like tuberculosis, heart disease, and oncology will keep increasing, thus helping to cure and diagnose.
Asia Pacific is anticipated to grow at a significant CAGR over the forecast period because of technological advancement, people's health awareness, and the increasing geriatric population across developing nations in the region, such as India and Japan.
Major players operating in the industry include Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin, F. Hoffmann-La Roche AG, Hologic, Inc., Illumina, Inc., InBios International, Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Merck KGaA, OraSure Technologies, Inc., Thermo Fisher Scientific Inc.
Polaris Market Research has segmented the Infectious Disease In Vitro Diagnostics market report based on Product, application, technology, end-use, and region:
Infectious Disease In Vitro Diagnostics, Product Outlook (Revenue - USD Billion, 2018 - 2030)
Instruments
Reagents
Software
Infectious Disease In Vitro Diagnostics, Technology Outlook (Revenue - USD Billion, 2018 - 2030)
Immunoassay
Molecular Diagnostics
Microbiology
Others
Infectious Disease In Vitro Diagnostics, Application Outlook (Revenue - USD Billion, 2018 - 2030)
MRSA
VRE
CRE
Clostridium Difficile
Streptococcus
Infectious Disease In Vitro Diagnostics, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Hospitals & Clinics
Diagnostic Laboratories
Academic Research Institutes
Others
Infectious Disease In Vitro Diagnostics, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Infectious Disease In Vitro Diagnostics Market Insights
- 4.1. Infectious Disease In Vitro Diagnostics - Industry Snapshot
- 4.2. Infectious Disease In Vitro Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing geriatric population
- 4.2.1.2. Technological advancements
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High prices of IVD tests
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Infectious Disease In Vitro Diagnostics Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Infectious Disease In Vitro Diagnostics Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 5.3. MRSA
- 5.3.1. Global Infectious Disease In Vitro Diagnostics Market, by MRSA, by Region, 2018 - 2030 (USD Billion)
- 5.4. VRE
- 5.4.1. Global Infectious Disease In Vitro Diagnostics Market, by VRE, by Region, 2018 - 2030 (USD Billion)
- 5.5. CRE
- 5.5.1. Global Infectious Disease In Vitro Diagnostics Market, by CRE, by Region, 2018 - 2030 (USD Billion)
- 5.6. Clostridium Difficile
- 5.6.1. Global Infectious Disease In Vitro Diagnostics Market, by Clostridium Difficile, by Region, 2018 - 2030 (USD Billion)
- 5.7. Streptococcus
- 5.7.1. Global Infectious Disease In Vitro Diagnostics Market, by Streptococcus, by Region, 2018 - 2030 (USD Billion)
6. Global Infectious Disease In Vitro Diagnostics Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 6.3. Instruments
- 6.3.1. Global Infectious Disease In Vitro Diagnostics Market, by Instruments, by Region, 2018 - 2030 (USD Billion)
- 6.4. Reagents
- 6.4.1. Global Infectious Disease In Vitro Diagnostics Market, by Reagents, by Region, 2018 - 2030 (USD Billion)
- 6.5. Software
- 6.5.1. Global Infectious Disease In Vitro Diagnostics Market, by Software, by Region, 2018 - 2030 (USD Billion)
7. Global Infectious Disease In Vitro Diagnostics Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 7.3. Immunoassay
- 7.3.1. Global Infectious Disease In Vitro Diagnostics Market, by Immunoassay, by Region, 2018 - 2030 (USD Billion)
- 7.4. Molecular Diagnostics
- 7.4.1. Global Infectious Disease In Vitro Diagnostics Market, by Molecular Diagnostics, by Region, 2018 - 2030 (USD Billion)
- 7.5. Microbiology
- 7.5.1. Global Infectious Disease In Vitro Diagnostics Market, by Microbiology, by Region, 2018 - 2030 (USD Billion)
- 7.6. Others
- 7.6.1. Global Infectious Disease In Vitro Diagnostics Market, by Others, by Region, 2018 - 2030 (USD Billion)
8. Global Infectious Disease In Vitro Diagnostics Market, by End-Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.3. Hospitals & Clinics
- 8.3.1. Global Infectious Disease In Vitro Diagnostics Market, by Hospitals & Clinics, by Region, 2018 - 2030 (USD Billion)
- 8.4. Diagnostic Laboratories
- 8.4.1. Global Infectious Disease In Vitro Diagnostics Market, by Diagnostic Laboratories, by Region, 2018 - 2030 (USD Billion)
- 8.5. Academic Research Institutes
- 8.5.1. Global Infectious Disease In Vitro Diagnostics Market, by Academic Research Institutes, by Region, 2018 - 2030 (USD Billion)
- 8.6. Others
- 8.6.1. Global Infectious Disease In Vitro Diagnostics Market, by Others, by Region, 2018 - 2030 (USD Billion)
9. Global Infectious Disease In Vitro Diagnostics Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Infectious Disease In Vitro Diagnostics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 9.3. Infectious Disease In Vitro Diagnostics Market - North America
- 9.3.1. North America: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.3.2. North America: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.3.3. North America: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.3.4. North America: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.3.5. Infectious Disease In Vitro Diagnostics Market - U.S.
- 9.3.5.1. U.S.: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.3.5.2. U.S.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.3.5.3. U.S.: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.3.5.4. U.S.: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.3.6. Infectious Disease In Vitro Diagnostics Market - Canada
- 9.3.6.1. Canada: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.3.6.2. Canada: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.3.6.3. Canada: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.3.6.4. Canada: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4. Infectious Disease In Vitro Diagnostics Market - Europe
- 9.4.1. Europe: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.2. Europe: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.3. Europe: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.4. Europe: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.5. Infectious Disease In Vitro Diagnostics Market - UK
- 9.4.5.1. UK: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.5.2. UK: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.5.3. UK: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.5.4. UK: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.6. Infectious Disease In Vitro Diagnostics Market - France
- 9.4.6.1. France: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.6.2. France: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.6.3. France: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.6.4. France: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.7. Infectious Disease In Vitro Diagnostics Market - Germany
- 9.4.7.1. Germany: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.7.2. Germany: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.7.3. Germany: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.7.4. Germany: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.8. Infectious Disease In Vitro Diagnostics Market - Italy
- 9.4.8.1. Italy: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.8.2. Italy: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.8.3. Italy: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.8.4. Italy: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.9. Infectious Disease In Vitro Diagnostics Market - Spain
- 9.4.9.1. Spain: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.9.2. Spain: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.9.3. Spain: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.9.4. Spain: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.10. Infectious Disease In Vitro Diagnostics Market - Netherlands
- 9.4.10.1. Netherlands: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.10.2. Netherlands: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.10.3. Netherlands: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.10.4. Netherlands: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.11. Infectious Disease In Vitro Diagnostics Market - Russia
- 9.4.11.1. Russia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.11.2. Russia.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.11.3. Russia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.11.4. Russia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5. Infectious Disease In Vitro Diagnostics Market - Asia Pacific
- 9.5.1. Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.2. Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.3. Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.4. Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.5. Infectious Disease In Vitro Diagnostics Market - China
- 9.5.5.1. China: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.5.2. China.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.5.3. China: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.5.4. China: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.6. Infectious Disease In Vitro Diagnostics Market - India
- 9.5.6.1. India: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.6.2. India.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.6.3. India: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.6.4. India: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.7. Infectious Disease In Vitro Diagnostics Market - Japan
- 9.5.7.1. Japan: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.7.2. Japan.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.7.3. Japan: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.7.4. Japan: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.8. Infectious Disease In Vitro Diagnostics Market - Malaysia
- 9.5.8.1. Malaysia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.8.2. Malaysia.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.8.3. Malaysia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.8.4. Malaysia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.9. Infectious Disease In Vitro Diagnostics Market - Indonesia
- 9.5.9.1. Indonesia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.9.2. Indonesia.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.9.3. Indonesia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.9.4. Indonesia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.10. Infectious Disease In Vitro Diagnostics Market - South Korea
- 9.5.10.1. South Korea: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.10.2. South Korea.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.10.3. South Korea: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.10.4. South Korea: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6. Infectious Disease In Vitro Diagnostics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.2. Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.3. Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.4. Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.5. Infectious Disease In Vitro Diagnostics Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.5.2. Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.5.3. Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.5.4. Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.6. Infectious Disease In Vitro Diagnostics Market - South Africa
- 9.6.6.1. South Africa: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.6.2. South Africa: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.6.3. South Africa: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.6.4. South Africa: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.7. Infectious Disease In Vitro Diagnostics Market - Israel
- 9.6.7.1. Israel: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.7.2. Israel: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.7.3. Israel: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.7.4. Israel: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.8. Infectious Disease In Vitro Diagnostics Market - UAE
- 9.6.8.1. UAE: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.8.2. UAE: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.8.3. UAE: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.8.4. UAE: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7. Infectious Disease In Vitro Diagnostics Market - Latin America
- 9.7.1. Latin America: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.2. Latin America: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.7.3. Latin America: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.7.4. Latin America: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.5. Infectious Disease In Vitro Diagnostics Market - Mexico
- 9.7.5.1. Mexico: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.5.2. Mexico: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.7.5.3. Mexico: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.7.5.4. Mexico: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.6. Infectious Disease In Vitro Diagnostics Market - Brazil
- 9.7.6.1. Brazil: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.6.2. Brazil: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.7.6.3. Brazil: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.7.6.4. Brazil: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.7. Infectious Disease In Vitro Diagnostics Market - Argentina
- 9.7.7.1. Argentina: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.7.2. Argentina: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.7.7.3. Argentina: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
- 9.7.7.4. Argentina: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abbott Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Becton Dickinson and Company
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Bio-Rad Laboratories, Inc
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Danaher Corporation
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. DiaSorin
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. F. Hoffmann-La Roche AG
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Hologic, Inc
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Illumina, Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. InBios International, Inc
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Koninklijke Philips N.V
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Laboratory Corporation of America Holdings
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Merck KGaA
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. OraSure Technologies, Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. PerkinElmer, Inc
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Qiagen N.V
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. Quest Diagnostics
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
- 11.17. Quidel Corporation
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
- 11.18. Siemens Healthcare AG
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development
- 11.19. Sysmex Corporation
- 11.19.1. Company Overview
- 11.19.2. Financial Performance
- 11.19.3. Product Benchmarking
- 11.19.4. Recent Development
- 11.20. Thermo Fisher Scientific Inc
- 11.20.1. Company Overview
- 11.20.2. Financial Performance
- 11.20.3. Product Benchmarking
- 11.20.4. Recent Development